chad-tricov/mac
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 29, 2021 (NCT05094609)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06381739 | Phase 2 | Jun 30, 2024 | Canadian Institutes of Health Research (CIHR), McMaster University |
| NCT05094609 | Phase 1 | Nov 29, 2021 | Canadian Institutes of Health Research (CIHR), McMaster University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 2 | 0 | 2 | 2021 |
| McMaster University | Academic/Hospital | 2 | 2 | 2 | 2021 |
2 organizations
Page 1 / 1